ZENTAMINE (Darbepoetin Alfa) is an erythropoiesis-stimulating agent produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. The final processed form is a 165-amino acid protein containing 5 N-linked oligosaccharide chains and 1 O-linked oligosaccharide chain. Darbepoetin Alfa injection causes the bone marrow to produce red blood cells in patients with severe anemia. Darbepoetin may be used for patients on kidney dialysis or for those not on dialysis.
ERYNEX is recombinant human erythropoietin alpha (rHuEPO). Erythropoietin is a glycoprotein, which stimulates red blood cell (Erythropoiesis) production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Erythropoietin stimulates erythropoiesis in anemic patients with chronic renal failure in whom the endogenous production of erythropoietin is impaired.
AMZEST-FE is a blend of essential vitamins which includes vitamin B complex along with Ferrous Ascorbate (eq. to elemental iron 100 mg), in tablet dosage form. People with chronic kidney disease (CKD) often cannot get enough of some vitamins & iron due to restricted diet. Supplementing iron in the diet prevents or treats Anemia.
AMZEST FE enhance RBC production, maintain haemoglobin level & lowers blood homocysteine level.
Iron delivery via liposomes is a promising approach to treat anemia effectively. Liposomes are one of the effective drug carrier systems which potentially deliver different therapeutic substances to specific molecular targets. Their biocompatibility, biodegradability and low toxicity make them suitable for delivering drugs. Geroz-LP a brand of ferric pyrophosphate that uses liposomal technology (i.e. micronized iron is incorporated into a phospholipid membrane, a sort of protective “shell”) and as compared to other traditional oral formulations, liposomal technology protects iron from drug interactions, allows better gastrointestinal absorption, results in higher bioavailability of the iron with lower incidence of side effects.